Prelude Capital Management, LLC Royalty Pharma PLC Transaction History

Prelude Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $627,900 - $716,391	22,866 New	22,866 $694,000
Q2 2023 Aug 14, 2023	BUY	$29.6 - $36.56 $27,942 - $34,512	944 Added 6.29%	15,944 $490,000
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $587,550 - $660,600	15,000 New	15,000 $592,000
Q2 2022 Aug 15, 2022	SELL	$37.53 - $44.22 $342,686 - $403,772	-9,131 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $342,047 - $387,519	9,131 New	9,131 $356,000
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $230,715 - $278,668	-6,560 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $237,078 - $277,094	6,560 New	6,560 $237,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.